| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Actuate Therapeutics, Inc. Common Stock (ACTU) have been net buyers, picking up 140,844 shares worth roughly $50K on balance. In the past 30 days, 1 insider bought and 0 sold.
Daniel M Schmitt (President, CEO and Director) stands out among recent buyers, now holding an estimated $155K in ACTU.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 904.8K | $316.7K | - | |
| CEO | 442.6K | $154.9K | +140.8K |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 14, 2024 | Leslie W. Kreis45 | 10% Owner | Buy | 500,000 | $8.00 | $4,000,000.00 | -133.3% | -1.4% | -10.2% | |
| Aug 14, 2024 | Bios Equity Cof, LP | Director, 10% Owner | Buy | 500,000 | $8.00 | $4,000,000.00 | -133.3% | -1.4% | -10.2% |